Skip to search formSkip to main contentSkip to account menu

Non-Small Cell Lung Carcinoma

Known as: Carcinomas, Non-Small-Cell Lung, Non Small Cell Lung Carcinoma, carcinoma cell lung non small 
A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of… 
National Institutes of Health

Related topics

Related topics

48 relations
AdenocarcinomaBlood supply aspectsCTLA4 geneCTLA4 protein, human

Broader (2)

CarcinomaMalignant neoplasm of lung

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
AbstractPurposeTo establish the potential for tumour heterogeneity in non-small cell lung cancer (NSCLC) as assessed by CT… 
Highly Cited
2010
Highly Cited
2010
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Purpose: To understand the role of nuclear factor erythroid-2–related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1… 
Highly Cited
2010
Highly Cited
2010
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death. Developing minimally invasive techniques that… 
Highly Cited
2005
Highly Cited
2005
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.
Treatment of second- and third-line patients with non-small-cell lung carcinoma (NSCLC) with the epidermal growth factor receptor… 
Highly Cited
2005
Highly Cited
2005
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic…
PURPOSE It has been reported that EGFR mutations in lung carcinomas make the disease more responsive to treatment with tyrosine… 
Highly Cited
2000
Highly Cited
2000
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
PURPOSE: To confirm the promising phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy… 
Highly Cited
1992
Highly Cited
1992
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
In some epithelial cells studied in vitro a membrane-bound folate receptor initiates the process for cell accumulation of 5… 
Highly Cited
1991
Highly Cited
1991
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
We report the results observed in a large, randomized study that compared the effects of radiotherapy alone (the standard therapy… 
Highly Cited
1989
Highly Cited
1989
Expression of Multidrug Resistance Gene in Human Cancers
Highly Cited
1986
Highly Cited
1986
The new International Staging System for Lung Cancer.
The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)